These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37596595)

  • 1. Perspectives of U.S. harm reduction advocates on persuasive message strategies.
    White SA; Lee R; Kennedy-Hendricks A; Sherman SG; McGinty EE
    Harm Reduct J; 2023 Aug; 20(1):112. PubMed ID: 37596595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framing harm reduction as part of an integrated approach to reduce drug overdose: A randomized message testing experiment in a nationally representative sample of U.S. adults, 2022.
    McGinty EE; White SA; Sherman SG; Lee R; Kennedy-Hendricks A
    Int J Drug Policy; 2023 Aug; 118():104101. PubMed ID: 37352766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Make yourself un-NIMBY-able": stakeholder perspectives on strategies to mobilize public and political support for overdose prevention centers in the United States of America.
    Rosen JG; Thompson E; Tardif J; Collins AB; Marshall BDL; Park JN
    Harm Reduct J; 2024 Feb; 21(1):40. PubMed ID: 38355641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study.
    Safi F; Rioux W; Rider N; Fornssler B; Jones S; Ghosh SM
    Harm Reduct J; 2023 May; 20(1):64. PubMed ID: 37158926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-Based Message Strategies to Increase Public Support for State Investment in Early Childhood Education: Results from a Longitudinal Panel Experiment.
    Niederdeppe J; Winett LB; Xu Y; Fowler EF; Gollust SE
    Milbank Q; 2021 Dec; 99(4):1088-1131. PubMed ID: 34402554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.
    Childs E; Biello KB; Valente PK; Salhaney P; Biancarelli DL; Olson J; Earlywine JJ; Marshall BDL; Bazzi AR
    Int J Drug Policy; 2021 Apr; 90():103080. PubMed ID: 33340947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder perspectives on implementing fentanyl drug checking: Results from a multi-site study.
    Glick JL; Christensen T; Park JN; McKenzie M; Green TC; Sherman SG
    Drug Alcohol Depend; 2019 Jan; 194():527-532. PubMed ID: 30551090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and opportunities from using abortion harm reduction and value clarification and attitude transformation engagements for safe abortion advocacy in Uganda.
    Kayondo SP; Kaye DK; Nabatanzi SL; Nassuuna S; Musana O; Namagembe I; Nsanja JP; Morris J; Fawzi H; de Koning K; Kaur J; Pretty M
    Reprod Health; 2023 Jun; 20(1):97. PubMed ID: 37381001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Having a voice and saving lives: a qualitative survey on employment impacts of people with lived experience of drug use working in harm reduction.
    ; Austin T; Boyd J
    Harm Reduct J; 2021 Jan; 18(1):1. PubMed ID: 33407500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the barriers and facilitators to implementing and sustaining Mobile Overdose Response Services from the perspective of Canadian key interest groups: a qualitative study.
    Seo B; Rider N; Rioux W; Teare A; Jones S; Taplay P; Monty Ghosh S
    Harm Reduct J; 2024 Feb; 21(1):28. PubMed ID: 38308262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How understanding and application of drug-related legal instruments affects harm reduction interventions in Cambodia: a qualitative study.
    Tuot S; Ngin C; Pal K; Sou S; Sawez G; Morgan P; Srey M; Chan T; Chhoun P; Golichenko O; Choub SC; Yi S
    Harm Reduct J; 2017 Jun; 14(1):39. PubMed ID: 28629463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is needed for implementing drug checking services in the context of the overdose crisis? A qualitative study to explore perspectives of potential service users.
    Wallace B; van Roode T; Pagan F; Phillips P; Wagner H; Calder S; Aasen J; Pauly B; Hore D
    Harm Reduct J; 2020 May; 17(1):29. PubMed ID: 32398090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings.
    Brinkley-Rubinstein L; Cloud DH; Davis C; Zaller N; Delany-Brumsey A; Pope L; Martino S; Bouvier B; Rich J
    Int J Prison Health; 2017 Mar; 13(1):25-31. PubMed ID: 28299971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moving towards a continuum of safer supply options for people who use drugs: A qualitative study exploring national perspectives on safer supply among professional stakeholders in Canada.
    Foreman-Mackey A; Pauly B; Ivsins A; Urbanoski K; Mansoor M; Bardwell G
    Subst Abuse Treat Prev Policy; 2022 Oct; 17(1):66. PubMed ID: 36209227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Why would we not want to keep everybody safe?' The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland.
    Parkes T; Price T; Foster R; Trayner KMA; Sumnall HR; Livingston W; Perkins A; Cairns B; Dumbrell J; Nicholls J
    Harm Reduct J; 2022 Aug; 19(1):99. PubMed ID: 36038919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Technologies to Identify Fentanyl and Adulterants in Street Drug Paraphernalia: Qualitative Perspectives of Service Providers and Their Clientele.
    Santelices C; Matsumoto A; Boulad M; Stopka TJ
    Subst Use Misuse; 2023; 58(12):1528-1535. PubMed ID: 37424449
    [No Abstract]   [Full Text] [Related]  

  • 19. The group-based law enforcement mistrust scale: psychometric properties of an adapted scale and implications for public health and harm reduction research.
    Johnson LM; Devereux PG; Wagner KD
    Harm Reduct J; 2022 Jun; 19(1):60. PubMed ID: 35658873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users.
    Wallace B; van Roode T; Pagan F; Hore D; Pauly B
    BMC Public Health; 2021 Jun; 21(1):1156. PubMed ID: 34134698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.